Researcher FAQ

How is disease endpoint X defined in FinnGen?
During FinnGen, a significant effort has been put into creating meaningful clinical endpoints based on the digital health record data from Finnish health registries. The research community can learn more about the details and best practices related to forming specific disease endpoints through the Risteys tool (https://risteys.finregistry.fi/) or by visiting the Clinical endpoints page (https://www.finngen.fi/en/researchers/clinical-endpoints).
How many FinnGen participants have a diagnosis X?
This information is available through the Risteys tool (https://risteys.finregistry.fi/) or the Endpoint Browser tool (https://geneviz.aalto.fi/endpoint_browser_2.0).
Can I get access to the FinnGen data?
Researchers affiliated to one of the FinnGen consortium partner organisations can get access to the data. Read more from our Partner Researchers page: https://www.finngen.fi/en/partner-researchers. Everybody can utilise our summary level results.
Can I get access to the SISu imputation reference panel?
Unfortunately we cannot share the reference panel outside the consortium.
Are you going to update the dataset regularly?
New data releases will be done once a year until 2027. The number of individuals will not increase but the health endpoints are updated and new data sources will be included.
Do you have sequence data from all the participants?
No, our genome data is based on a tailored genotyping array and imputation. The imputation reference dataset derived from Finnish whole-genome sequences, encompassing approximately 8700 individuals.